首页> 外文期刊>Global Pediatric Health >Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
【24h】

Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database

机译:日本儿童哮喘控制药物:行政索赔数据库的分析

获取原文
       

摘要

Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications, in children. Methods. A retrospective cohort study was performed in children with asthma using an administrative claims database in Japan. Results. A total of 1149 preschool-age and 3226 school-age children were identified. Leukotriene receptor antagonists were prescribed for about 80% of the children. Long-acting β-agonists were prescribed for 87.6% and 59.6% of preschool-age and school-age children, respectively, whereas prescriptions of inhaled corticosteroids had lower rates of 8.2% and 16.5%, respectively. In an examination of prescriptions at 1-month intervals, a relatively high number of children were prescribed bronchodilators without anti-inflammatory agents. Conclusion. Our findings suggest that asth...
机译:背景。国际上儿童哮喘的治疗和管理策略在国际上通常是一致的,但是不同国家使用抗哮喘药的处方有所不同。这项研究的目的是检查儿童抗哮喘药的处方模式,尤其是控制药物。方法。一项回顾性队列研究是在日本使用行政声明数据库对哮喘患儿进行的。结果。总共确定了1149个学龄前儿童和3226个学龄儿童。约有80%的儿童开了白三烯受体拮抗剂。学龄前和学龄儿童的长效β受体激动剂的处方率分别为87.6%和59.6%,而吸入性糖皮质激素的处方率分别较低,分别为8.2%和16.5%。在每隔1个月检查一次处方时,有相对较高的儿童接受了不使用抗炎药的支气管扩张剂处方。结论。我们的发现表明,...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号